1. Home
  2. QQQX vs TXG Comparison

QQQX vs TXG Comparison

Compare QQQX & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QQQX
  • TXG
  • Stock Information
  • Founded
  • QQQX 2007
  • TXG 2012
  • Country
  • QQQX United States
  • TXG United States
  • Employees
  • QQQX N/A
  • TXG N/A
  • Industry
  • QQQX Finance Companies
  • TXG Biotechnology: Laboratory Analytical Instruments
  • Sector
  • QQQX Finance
  • TXG Industrials
  • Exchange
  • QQQX Nasdaq
  • TXG Nasdaq
  • Market Cap
  • QQQX 1.3B
  • TXG 1.5B
  • IPO Year
  • QQQX N/A
  • TXG 2019
  • Fundamental
  • Price
  • QQQX $26.89
  • TXG $10.90
  • Analyst Decision
  • QQQX
  • TXG Buy
  • Analyst Count
  • QQQX 0
  • TXG 16
  • Target Price
  • QQQX N/A
  • TXG $20.36
  • AVG Volume (30 Days)
  • QQQX 127.6K
  • TXG 2.9M
  • Earning Date
  • QQQX 01-01-0001
  • TXG 02-12-2025
  • Dividend Yield
  • QQQX 7.03%
  • TXG N/A
  • EPS Growth
  • QQQX N/A
  • TXG N/A
  • EPS
  • QQQX N/A
  • TXG N/A
  • Revenue
  • QQQX N/A
  • TXG $610,785,000.00
  • Revenue This Year
  • QQQX N/A
  • TXG $4.38
  • Revenue Next Year
  • QQQX N/A
  • TXG $9.08
  • P/E Ratio
  • QQQX N/A
  • TXG N/A
  • Revenue Growth
  • QQQX N/A
  • TXG N/A
  • 52 Week Low
  • QQQX $20.27
  • TXG $10.80
  • 52 Week High
  • QQQX $25.99
  • TXG $48.42
  • Technical
  • Relative Strength Index (RSI)
  • QQQX 43.95
  • TXG 24.63
  • Support Level
  • QQQX $26.83
  • TXG $11.43
  • Resistance Level
  • QQQX $27.50
  • TXG $13.12
  • Average True Range (ATR)
  • QQQX 0.27
  • TXG 0.98
  • MACD
  • QQQX -0.02
  • TXG -0.24
  • Stochastic Oscillator
  • QQQX 12.86
  • TXG 2.27

About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest

Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Share on Social Networks: